These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 10925353)

  • 1. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
    Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
    Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
    Dolfini E; Dasdia T; Arancia G; Molinari A; Calcabrini A; Scheper RJ; Flens MJ; Gariboldi MB; Monti E
    Br J Cancer; 1997; 76(1):67-76. PubMed ID: 9218735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution.
    Cheng SH; Lam W; Lee AS; Fung KP; Wu RS; Fong WF
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):134-42. PubMed ID: 10764626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
    Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
    Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
    Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular P-glycoprotein in multidrug resistant tumor cells.
    Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane transport proteins associated with drug resistance expressed in human melanoma.
    Schadendorf D; Makki A; Stahr C; van Dyck A; Wanner R; Scheffer GL; Flens MJ; Scheper R; Henz BM
    Am J Pathol; 1995 Dec; 147(6):1545-52. PubMed ID: 7495278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.
    Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M
    Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.
    Meschini S; Marra M; Calcabrini A; Monti E; Gariboldi M; Dolfini E; Arancia G
    Toxicol In Vitro; 2002 Aug; 16(4):389-98. PubMed ID: 12110277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional activity of ABC transporters (markers of multidrug resistance) in human colon adenocarcinoma and normal colonic mucosa].
    Bogush EA; Ravcheeva AB; Konukhova AV; Bogush TA; Komov DV; Baryshnikov AIu; Kalganov ID; Zhuchenko AP
    Antibiot Khimioter; 2002; 47(8):3-8. PubMed ID: 12515089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
    Uchiyama-Kokubu N; Watanabe T
    Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug retention, efflux, and resistance in tumor cells.
    Krishan A; Fitz CM; Andritsch I
    Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
    Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
    J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.
    Alexander D; Yamamoto T; Kato S; Kasai S
    Surg Today; 1999; 29(5):401-6. PubMed ID: 10333409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
    Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
    J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.